@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_head { this: np:hasAssertion dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_assertion; np:hasProvenance dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_provenance; np:hasPublicationInfo dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_publicationInfo; a np:Nanopublication . dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_assertion a np:Assertion . dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_provenance a np:Provenance . dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_publicationInfo a np:PublicationInfo . } dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_assertion { miriam-gene:4858 a ncit:C16612 . lld:C0699753 a ncit:C7057 . dgn-gda:DGNba4eacdb66757d052b4eafd0686e37f9 sio:SIO_000628 miriam-gene:4858, lld:C0699753; a sio:SIO_001121 . } dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_provenance { dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_assertion dcterms:description "[Relationships between comet variables and clinical parameters, found with principal component analysis, correlations, one-way ANOVA and multivariate logistic regression analyses revealed that: (1) baseline levels of DNA damage are related to GSTM1 genotype and to hormonal receptor expression; (2) GSTM1 genotype also influences comet results after chemotherapy, as it does the AST level; (3) the tail moment values of the cycle 6.1 and the sickness stage might predict cancer relapse at five years: for the Stage, OR = 13.8 (IIB versus I+IIA), 95% CI 0.80-238.97, and for 6.1 cycle TM, OR = 1.3, 95%, CI 0.97-1.79, with a potential model (10* Stage (I-IIA = 0, IIB = 1) + 6.1 cycle), that has a good predictive capacity, with an area under ROC curve of 0.872 (CI 0.62-1.00).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:22987025; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP386908.RAKZX90giAb-HAADt-hgEVxPwNMXxKU1vlupF7w6IhwjE130_publicationInfo { this: dcterms:created "2014-10-02T12:35:50+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }